Acuity Spatial Genomics, Inc
Chad Sanada is a Senior Staff Scientist at Acuity Spatial Genomics, Inc., with a robust background in product development, data analysis, and project management. Prior experience includes a Staff Scientist role at Cellanome and a position at Inscripta, Inc. where Chad led troubleshooting efforts for genome engineering instruments. Previously, Chad held senior scientist roles at Fluidigm Corporation and contributed significant research as a postdoctoral fellow at Yale University School of Medicine, focusing on human hematopoiesis. Chad's educational background includes a Ph.D. in Stem Cell Biology from the University of Nevada School of Medicine and a B.S. in Chemistry from Southern Utah University.
Acuity Spatial Genomics, Inc
Acuity Spatial Genomics, Inc. provides a ground-breaking platform designed for simultaneous, genome-wide visualization of the 3D genome in single cells and opens new frontiers in spatial multiomic analyses for discovery. Based on patented technologies developed at Harvard University, the company’s OligoFISSEQ and OligoFISSEQ HD technologies empower researchers to visualize the genome organization and 3D chromatin architecture of individual cells, directly in situ, and in an accessible time-to-result and cost-effective approach. The Acuity technology platform enables the possibility to delve deeper and gain critical insight into transcription regulatory programs that drive cell type, state, function, and pathogenesis—and thus advance discovery in areas such as oncology, neuroscience, and disease research. The company has facilities in Massachusetts and California.